Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRC
2876
DELISTED
First Republic Bank
FRC
| $5.23M | ﹤0.01% |
+44,510
| New | +$4.81M |
|
2877
PUT
ProShares VIX Mid-Term Futures ETF
VIXM
$154M
| $5.23M | ﹤0.01% |
245,500
+47,100
| +24% | +$1.06M |
|
|
NS
2878
PUT
DELISTED
NuStar Energy L.P.
NS
| $5.23M | ﹤0.01% |
202,200
+6,200
| +3% | +$173K |
|
|
SEM
2879
CALL
DELISTED
Select Medical
SEM
| $5.23M | ﹤0.01% |
415,558
+392,172
| +1,677% | +$4.22M |
|
|
ACB
2880
PUT
Aurora Cannabis
ACB
$251M
| $5.22M | ﹤0.01% |
20,159
-11,025
| -35% | -$4.11M |
|
2881
Madrigal Pharmaceuticals
MDGL
$12.3B
| $5.22M | ﹤0.01% |
57,337
+41,677
| +266% | +$4.04M |
|
|
DNKN
2882
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $5.21M | ﹤0.01% |
69,000
-45,100
| -40% | -$3.41M |
|
2883
CALL
Viking Therapeutics
VKTX
$3.84B
| $5.21M | ﹤0.01% |
649,600
-231,600
| -26% | -$1.69M |
|
2884
Dave & Buster's
PLAY
$328M
| $5.2M | ﹤0.01% |
129,548
+59,041
| +84% | +$2.36M |
|
2885
CALL
Fastly Inc
FSLY
$3.74B
| $5.19M | ﹤0.01% |
258,800
+45,300
| +21% | +$955K |
|
|
INFN
2886
CALL
DELISTED
Infinera Corporation Common Stock
INFN
| $5.19M | ﹤0.01% |
653,500
+215,200
| +49% | +$1.32M |
|
2887
PUT
Alliance Resource Partners
ARLP
$3.38B
| $5.19M | ﹤0.01% |
479,500
+381,400
| +389% | +$4.58M |
|
2888
Synopsys
SNPS
$85.7B
| $5.19M | ﹤0.01% |
37,255
+34,456
| +1,231% | +$4.73M |
|
2889
PUT
YPF Sociedad Anonima ADS
YPF
$19.8B
| $5.18M | ﹤0.01% |
447,400
-967,800
| -68% | -$9.39M |
|
2890
PUT
iShares US Healthcare Providers ETF
IHF
$1.24B
| $5.18M | ﹤0.01% |
129,000
-8,500
| -6% | -$312K |
|
2891
CALL
British American Tobacco
BTI
$121B
| $5.17M | ﹤0.01% |
121,700
-292,800
| -71% | -$11M |
|
2892
Hormel Foods
HRL
$11.8B
| $5.17M | ﹤0.01% |
114,548
+2,393
| +2% | +$103K |
|
2893
CALL
PennyMac Financial
PFSI
$3.86B
| $5.17M | ﹤0.01% |
151,800
+72,700
| +92% | +$2.36M |
|
2894
PUT
Karyopharm Therapeutics
KPTI
$43.1M
| $5.16M | ﹤0.01% |
17,947
+7,827
| +77% | +$1.7M |
|
2895
Seagate
STX
$191B
| $5.15M | ﹤0.01% |
86,604
-98,812
| -53% | -$5.68M |
|
2896
CALL
MKS Inc
MKSI
$17.8B
| $5.15M | ﹤0.01% |
46,800
+11,000
| +31% | +$1.15M |
|
2897
PUT
Bio-Rad Laboratories Class A
BIO
$10.4B
| $5.14M | ﹤0.01% |
13,900
-11,600
| -45% | -$4.09M |
|
2898
CALL
NOV
NOV
$7.33B
| $5.14M | ﹤0.01% |
205,300
+32,300
| +19% | +$727K |
|
|
ATH
2899
CALL
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $5.14M | ﹤0.01% |
109,300
+62,500
| +134% | +$2.72M |
|
2900
CALL
Agios Pharmaceuticals
AGIO
$2B
| $5.14M | ﹤0.01% |
107,600
+60,500
| +128% | +$2.29M |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.